Meenakshi Rana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meenakshi Rana has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Sidhant Jain
Institute for Globally Distributed Open Research and Education (IGDORE), India
5 shared publications - Divya Bajaj
Department of Zoology, Hindu College, University of Delhi, Delhi, India
3 shared publications Pooja Choubey
Department of Zoology, University of Delhi, India
3 shared publicationsGouri Nandi
Department of Zoology, University of Delhi, India; Department of Zoology, Deshbandhu College, University of Delhi, India
1 shared publication- Gouri Nandi
Department of Zoology, University of Delhi, Delhi, 110007, India; Department of Zoology, Deshbandhu College, University of Delhi, Delhi, 110019, India
1 shared publication Sharmila Basu-Modak
Department of Zoology, University of Delhi, New Delhi, India
1 shared publication
Latest Publications
- 25 September 2025
- Published by Elsevier in Developmental Biology
- Vol. 528, 264-276
VEGF and its receptors expression in relation to reduced vasculature phenotype in heme oxygenase 1 knockout mouse embryos
- 25 September 2025
- Published by Elsevier in Developmental Biology
- Vol. 528, 264-276
VEGF and its receptors expression in relation to reduced vasculature phenotype in heme oxygenase 1 knockout mouse embryos
- 17 November 2023
- Published by Elsevier in Reproductive Biology
- Vol. 23 (4) , 100822
Expression of angiogenic factors in the placenta of heme oxygenase-1 deficient mouse embryo
- 17 November 2023
- Published by Elsevier in Reproductive Biology
- Vol. 23 (4) , 100822
Expression of angiogenic factors in the placenta of heme oxygenase-1 deficient mouse embryo
- 22 July 2023
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 71 (8) , 431-450
Altered Expression of Heme Oxygenase 2 in Heme Oxygenase 1–deficient Mouse Embryos
Heme oxygenases (Hmoxs) are enzymes that catalyze the first and rate-limiting step in the degradation of heme to carbon monoxide, iron, and biliverdin. The two main isozymes, namely Hmox1 and Hmox2, are encoded by two different genes. Mutation of the Hmox1 gene in mice is known to cause extensive prenatal lethality, and limited information is available about the expression of Hmox proteins in developing mouse embryos. In this study, immunohistochemistry was used to perform a detailed investigation comparing Hmox proteins in Hmox1 wild-type and knockout (KO) mouse embryos collected from wild-type and heterozygous timed-matings. Western analysis for Hmoxs was also done in the organs of late-gestation embryos. The results demonstrated cytoplasmic and nuclear localization of Hmoxs in all the organs examined in wild-type embryos. Interestingly, Hmox2 immunoreactive protein signals were significantly low in most of the organs of mid- and late-gestation Hmox1-KO embryos. Furthermore, relative levels of Hmox2 were revealed to be significantly lower in the lung and kidney of late-gestation Hmox1-KO embryos by western analysis, which complemented the immunohistochemistry findings in these two organs. The current study provides detailed immunoexpression patterns of Hmox proteins in wild-type and Hmox1-KO mouse embryos in mid- and late-gestation:
- 22 July 2023
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 71 (8) , 431-450
Altered Expression of Heme Oxygenase 2 in Heme Oxygenase 1–deficient Mouse Embryos
Heme oxygenases (Hmoxs) are enzymes that catalyze the first and rate-limiting step in the degradation of heme to carbon monoxide, iron, and biliverdin. The two main isozymes, namely Hmox1 and Hmox2, are encoded by two different genes. Mutation of the Hmox1 gene in mice is known to cause extensive prenatal lethality, and limited information is available about the expression of Hmox proteins in developing mouse embryos. In this study, immunohistochemistry was used to perform a detailed investigation comparing Hmox proteins in Hmox1 wild-type and knockout (KO) mouse embryos collected from wild-type and heterozygous timed-matings. Western analysis for Hmoxs was also done in the organs of late-gestation embryos. The results demonstrated cytoplasmic and nuclear localization of Hmoxs in all the organs examined in wild-type embryos. Interestingly, Hmox2 immunoreactive protein signals were significantly low in most of the organs of mid- and late-gestation Hmox1-KO embryos. Furthermore, relative levels of Hmox2 were revealed to be significantly lower in the lung and kidney of late-gestation Hmox1-KO embryos by western analysis, which complemented the immunohistochemistry findings in these two organs. The current study provides detailed immunoexpression patterns of Hmox proteins in wild-type and Hmox1-KO mouse embryos in mid- and late-gestation:
- 11 May 2022
- Published by Springer Nature in Hormones
- Vol. 21 (2) , 209-219
Prolactin and its significance in the placenta
Prolactin, a pituitary hormone that was discovered about 80 years ago and is primarily known for its functions in mammary gland development and lactation, is now known to participate in numerous functions across different phylogenetic groups. Fundamentally known for its secretion from lactotroph cells in adenohypophysis region of pituitary gland, newer studies have demonstrated a number of extrapituitary sites which secrete prolactin, where it acts in an autocrine, paracrine, and endocrine manner to regulate essential physiological and biochemical processes. These sites include lymphocytes, epithelial cells of lactating mammary glands, breast cancer cells of epithelial origin, and the placenta. The placenta is one of the most important organs secreting prolactin; however, its role in placental biology has not to date been reviewed comprehensively. This review elaborates upon the various facets of prolactin hormone, including prolactin production and its post-translational modifications and signaling. Major emphasis is placed on placental prolactin and its potential roles, ranging from the role of prolactin in angiogenesis, preeclampsia, maternal diabetes, and anti-apoptosis, among others.
- 11 May 2022
- Published by Springer Nature in Hormones
- Vol. 21 (2) , 209-219
Prolactin and its significance in the placenta
Prolactin, a pituitary hormone that was discovered about 80 years ago and is primarily known for its functions in mammary gland development and lactation, is now known to participate in numerous functions across different phylogenetic groups. Fundamentally known for its secretion from lactotroph cells in adenohypophysis region of pituitary gland, newer studies have demonstrated a number of extrapituitary sites which secrete prolactin, where it acts in an autocrine, paracrine, and endocrine manner to regulate essential physiological and biochemical processes. These sites include lymphocytes, epithelial cells of lactating mammary glands, breast cancer cells of epithelial origin, and the placenta. The placenta is one of the most important organs secreting prolactin; however, its role in placental biology has not to date been reviewed comprehensively. This review elaborates upon the various facets of prolactin hormone, including prolactin production and its post-translational modifications and signaling. Major emphasis is placed on placental prolactin and its potential roles, ranging from the role of prolactin in angiogenesis, preeclampsia, maternal diabetes, and anti-apoptosis, among others.
- 31 March 2021
- Published by Taylor & Francis in Journal of Homosexuality
- Vol. 69 (6) , 1004-1029
Alternative Sexual Orientation in Humans: What Is Known and What Needs to Be Known Further
Since the 20th century, multiple studies have linked the variations in human sexual orientation, from heterosexuality to bisexuality or homosexuality, to a wide range of biological factors. However, a clear mechanism that leads to the development of these variations has not been established yet. This review consolidates various comprehensive studies on the possible biological factors in the fields of genetics, epigenetics, uterine environment, hormones, neuroanatomy, and neurobiology that lead to these variations. One intriguing question that ‘homosexuality phenotype’ faces is its ability to avoid elimination by Darwinian selection. This review tries to explain why natural selection is not eliminating the genetic factors associated with homosexuality even at the cost of the evolutionary fitness of homosexual individuals. Studies supporting certain strong candidates for alternative sexual orientation (ASO) are highlighted, which can become new research avenues for investigators in this field. Further, a novel speculation is proposed that might be contributing to the development of variation in human sexuality.
- 31 March 2021
- Published by Taylor & Francis in Journal of Homosexuality
- Vol. 69 (6) , 1004-1029
Alternative Sexual Orientation in Humans: What Is Known and What Needs to Be Known Further
Since the 20th century, multiple studies have linked the variations in human sexual orientation, from heterosexuality to bisexuality or homosexuality, to a wide range of biological factors. However, a clear mechanism that leads to the development of these variations has not been established yet. This review consolidates various comprehensive studies on the possible biological factors in the fields of genetics, epigenetics, uterine environment, hormones, neuroanatomy, and neurobiology that lead to these variations. One intriguing question that ‘homosexuality phenotype’ faces is its ability to avoid elimination by Darwinian selection. This review tries to explain why natural selection is not eliminating the genetic factors associated with homosexuality even at the cost of the evolutionary fitness of homosexual individuals. Studies supporting certain strong candidates for alternative sexual orientation (ASO) are highlighted, which can become new research avenues for investigators in this field. Further, a novel speculation is proposed that might be contributing to the development of variation in human sexuality.